Cymbalta for Anxiety
Links shared publicly online about this topic
Cymbalta for Chronic Pain
hcplive.com — “FDA is considering approving Cymbalta as a treatment for chronic pain.” View full resource at hcplive.com
Most Recently Shared on August 17, 2010 at 7:14 pm By:
Cymbalta for Chronic Pain http://hcp.lv/92YpHH
FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder
drugs.com — “Cymbalta (duloxetine) is used for the maintenance treatment of generalized anxiety disorder. Includes Cymbalta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 30, 2009 at 11:46 pm By:
FDA Approves Cymbalta for Maintenance Treatment of Generalized Anxiety Disorder - http://bit.ly/8jffpy
Eli Lilly and Company - FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
newsroom.lilly.com — “Eli Lilly and Company - FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder” View full resource at newsroom.lilly.com
Most Recently Shared on November 30, 2009 at 2:41 pm By:
eyeonfda Pharma and Health Lawyer
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder - http://ow.ly/H9vE
RxEconsult, LLC - Cymbalta (duloxetine) for depression, anxiety, fibromyalgia, neuropathic and musculoskeletal pain
rxeconsult.com — “RxEconsult, LLC - Cymbalta (duloxetine) for depression, anxiety, fibromyalgia, neuropathic and musculoskeletal pain” View full resource at rxeconsult.com
Most Recently Shared on October 15, 2011 at 2:58 pm By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD
#Cymbalta (duloxetine) for #depression, #anxiety, #fibromyalgia, and #pain http://t.co/EUbIxOp3 #medications #health #diabetes
Cymbalta approved for maintenance treatment of generalized anxiety disorder (GAD) - MPR
empr.com — “The FDA has approved Cymbalta (duloxetine HCl, from Lilly) for the maintenance treatment of generalized anxiety disorder (GAD) in adults.” View full resource at empr.com
Most Recently Shared on November 30, 2009 at 4:52 pm By:
MPR News: Cymbalta approved for maintenance treatment of generalized anxiety disorder (GAD): The FDA has approved C... http://bit.ly/5AU8sB
FDA Approves Cymbalta for Chronic Musculoskeletal Pain
webmd.com — “A drug used to treat depression, anxiety, fibromyalgia, and diabetic neuropathy has been approved by the FDA for a new use -- to treat chronic musculoskeletal pain, including pain caused by osteoarthritis and chronic low back pain.” View full resource at webmd.com
Most Recently Shared on November 5, 2010 at 2:17 pm By:
FDA Approves Cymbalta for Chronic Musculoskeletal Pain http://bit.ly/9pH0fw
Lilly resubmits application for Cymbalta - MarketWatch
marketwatch.com — “BOSTON (MarketWatch) -- Eli Lilly & Co. said Wednesday that it has resubmitted its application to have its antidepressant Cymbalta approved to also treat chronic pain. Cymbalta is already approved in the U.S. to treat major depression, generalized anxiety disorder, and pain associated with fibromyalgia and diabetic neuropathy. Lilly originally applied to have the product approved for chronic pain in the second quarter 2008, but later withdrew the application after regulators questioned the d” View full resource at marketwatch.com
Most Recently Shared on June 3, 2009 at 6:55 pm By:
Lilly resubmits application for Cymbalta - MarketWatch http://tinyurl.com/ql29ku
FDA approves Cymbalta as maintenance drug for anxiety disorder - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA cleared Eli Lilly and Co. to market Cymbalta as a maintenance therapy for generalized anxiety disorder. Cymbalta, which was first approved in 2004 as an antidepressant, already has FDA approval to treat acute attacks of generalized anxiety disorder. ” View full resource at smartbrief.com
Most Recently Shared on December 1, 2009 at 4:25 pm By:
Women In Pain Health Organization
FDA approves Cymbalta as maintenance drug for anxiety disorder http://sbne.ws/r/3mH8
Medications for Anxiety : Anxiety
spectrumville.net — “Medications for Anxiety : Anxiety” View full resource at spectrumville.net
Most Recently Shared on July 5, 2011 at 5:43 pm By:
Asperger's Forum Support and Health Executive
Right now my doctors have me on wellbutrin and cymbalta and buspirone. Buspirone and wellbut... http://bit.ly/kNyrV8 #aspergers #autism
Cymbalta (duloxetine) Drug Information by MedicineNet.com
medicinenet.com — “Read about Cymbalta (duloxetine), a drug prescribed for neuropathic pain associated with diabetic peripheral neuropathy, depression, and anxiety. Side effect, dosage, and drug interaction information included.” View full resource at medicinenet.com
Most Recently Shared on January 7, 2012 at 5:45 am By:
Scott Pearlman, M.D. Active Health Library, Doctor, Emergency Physician, and Physician
duloxetine, Cymbalta: Title: duloxetine, CymbaltaCategory: MedicationsCreated: 7/11/2007Last Edito... http://t.co/WGFk49xd #mentalhealth
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain
spine-health.com — “Read what conditions the FDA advisory panel recommends for Cymbalta to treat.” View full resource at spine-health.com
Most Recently Shared on August 26, 2010 at 12:57 am By:
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain http://bit.ly/cuD8sU
FDA: Anti-depressant Cymbalta can also relieve back pain
nydailynews.com — “The drug is also approved to treat depression, anxiety, diabetes-related pain and fiomyalgia.” View full resource at nydailynews.com
Most Recently Shared on November 5, 2010 at 7:10 pm By:
FDA: Anti-depressant Cymbalta can also relieve back pain http://bit.ly/9pP0nk
Google Sidewiki entry about Cymbalta (duloxetine HCl): Official Site
google.com — “First Cymbalta was approved for GAD (generalized anxiety disorder), then the buzz machine went into action to imply that Cymbalta can cure back pain! What next? No wonder Cymbalta was #5 among the TOP 20 DTC advertisers in Q1 2009, spending $39.3 million that quarter. See these Pharma Marketing Blog posts: eGAD! How I Learned to Stop Worrying and Love Cymbalta! <” View full resource at google.com
Most Recently Shared on October 5, 2009 at 5:18 pm By:
Just wrote a Sidewiki entry on "Cymbalta Official Site" http://bit.ly/ylsMx What isn't it good for? #5 TOP DTC spender in Q1 2009.
Impax Laboratories Receives Tentative FDA Approval For Generic Cymbalta(R) Delayed-Release 20, 30 And 60 Mg Capsules
medicalnewstoday.com — “Impax Laboratories, Inc. (NASDAQ: IPXL) confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic vers” View full resource at medicalnewstoday.com
Most Recently Shared on November 25, 2010 at 12:21 pm By:
Impax Laboratories Receives Tentative FDA Approval For Generic Cymbalta(R) Delayed-Release 20, 30 And 60 Mg Capsules http://sns.ly/6At67
Impax Laboratories Receives Tentative FDA Approval For Generic Cymbalta(R) Delayed-Release 20, 30 And 60 Mg Capsules
medicalnewstoday.com — “Impax Laboratories, Inc. (NASDAQ: IPXL) confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application for generic vers” View full resource at medicalnewstoday.com
Most Recently Shared on November 25, 2010 at 2:05 pm By:
Impax Laboratories Receives Tentative FDA Approval For Generic Cymbalta(R) Delayed-Release 20, 30 And 60 Mg Capsules http://mnt.to/3N9d
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Advertisement
